Swiss Life Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76M Sell
209,837
-11,622
-5% -$3.98M 0.31% 62
2026
Q1
$77.9M Buy
221,459
+23,333
+12% +$8.32M 0.38% 52
2025
Q4
$64.8M Sell
198,126
-73,214
-27% -$23.2M 0.33% 57
2025
Q3
$76.6M Buy
271,340
+6,082
+2% +$1.76M 0.4% 47
2025
Q2
$74.1M Sell
265,258
-13,841
-5% -$3.92M 0.44% 49
2025
Q1
$87M Buy
279,099
+18,375
+7% +$5.43M 0.63% 29
2024
Q4
$67.9M Buy
260,724
+107,818
+71% +$32M 0.5% 37
2024
Q3
$49.2M Sell
152,906
-22,967
-13% -$7.51M 0.56% 31
2024
Q2
$54.9M Buy
175,873
+62,642
+55% +$18.4M 0.65% 25
2024
Q1
$32.2M Sell
113,231
-16,864
-13% -$4.93M 0.45% 55
2023
Q4
$37.5M Sell
130,095
-17,274
-12% -$4.71M 0.45% 36
2023
Q3
$39.6M Buy
147,369
+28,849
+24% +$7.2M 0.61% 26
2023
Q2
$26.3M Sell
118,520
-1,494
-1% -$347K 0.39% 42
2023
Q1
$29M Sell
120,014
-20,789
-15% -$5.1M 0.44% 36
2022
Q4
$37M Sell
140,803
-7,857
-5% -$2.11M 0.62% 27
2022
Q3
$33.5M Buy
148,660
+21,140
+17% +$5.12M 0.58% 32
2022
Q2
$31.1M Buy
127,520
+1,318
+1% +$323K 0.5% 33
2022
Q1
$30.5M Sell
126,202
-5,173
-4% -$1.19M 0.43% 43
2021
Q4
$29.6M Buy
131,375
+5,259
+4% +$1.11M 0.38% 52
2021
Q3
$26.8M Buy
126,116
+2,151
+2% +$495K 0.37% 57
2021
Q2
$24.3M Buy
123,965
+3,216
+3% +$791K 0.25% 65
2021
Q1
$30M Sell
120,749
-9,723
-7% -$2.32M 0.43% 45
2020
Q4
$30M Sell
130,472
-99,098
-43% -$22.8M 0.44% 43
2020
Q3
$58.3M Buy
229,570
+19,469
+9% +$4.82M 0.87% 20
2020
Q2
$49.6M Buy
210,101
+1,383
+0.7% +$316K 0.8% 25
2020
Q1
$42.3M Buy
208,718
+26,783
+15% +$5.85M 0.8% 25
2019
Q4
$43.9M Sell
181,935
-137,171
-43% -$30.2M 0.83% 26
2019
Q3
$61.7M Sell
319,106
-69,636
-18% -$13.4M 0.81% 30
2019
Q2
$71.6M Buy
388,742
+33,902
+10% +$6.07M 0.87% 26
2019
Q1
$67.4M Buy
354,840
+45,230
+15% +$8.64M 0.85% 27
2018
Q4
$60.3M Sell
309,610
-17,030
-5% -$3.32M 1.23% 17
2018
Q3
$67.7M Buy
326,640
+16,691
+5% +$3.29M 0.91% 21
2018
Q2
$57.2M Buy
309,949
+8,273
+3% +$1.46M 0.86% 22
2018
Q1
$51.4M Buy
301,676
+31,295
+12% +$5.74M 0.9% 19
2017
Q4
$47M Buy
270,381
+59,494
+28% +$10.5M 1.05% 19
2017
Q3
$39.3M Sell
210,887
-3,524
-2% -$624K 1.05% 20
2017
Q2
$36.9M Sell
214,411
-2,774
-1% -$451K 0.95% 17
2017
Q1
$35.6M Buy
217,185
+35,132
+19% +$5.84M 0.96% 18
2016
Q4
$26.6M Buy
182,053
+64,723
+55% +$9.74M 0.89% 23
2016
Q3
$19.6M Buy
117,330
+7,655
+7% +$1.29M 0.67% 33
2016
Q2
$16.7M Hold
109,675
0.69% 35
2016
Q1
$16.4M Hold
109,675
0.69% 29
2015
Q4
$17.8M Sell
109,675
-900
-0.8% -$141K 0.79% 24
2015
Q3
$15.3M Buy
110,575
+10,241
+10% +$1.61M 0.74% 27
2015
Q2
$15.4M Buy
100,334
+2,817
+3% +$451K 0.54% 25
2015
Q1
$15.6M Buy
+97,517
New +$15.4M 0.63% 23

Other funds holding AMGN

Swiss Life Asset Management's AMGN Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Amgen (AMGN) stake by 5.2% in Q2 2026, selling an estimated $3.98M and leaving 209,837 shares worth $76M. The position accounts for 0.31% of the portfolio, ranked #62.

Swiss Life Asset Management first reported a position in AMGN in Q1 2015 and has held it in 46 quarters since. The position peaked at $87M in Q1 2025. 2,457 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Swiss Life Asset Management held 209,837 shares of Amgen worth $76M as of Q2 2026.
  • Swiss Life Asset Management sold 11,622 Amgen shares in Q2 2026, an estimated $3.98M.
  • Amgen made up 0.31% of Swiss Life Asset Management's portfolio in Q2 2026, its #62 holding.
  • Swiss Life Asset Management first reported a position in Amgen in Q1 2015 and has held it in 46 quarters since.
  • Swiss Life Asset Management's Amgen position peaked at $87M in Q1 2025.
  • 2,457 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.